Global Nanopore Sequencing Markets, Competition, Forecast & Opportunities, 2021-2026 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Nanopore Sequencing Market, By Product (Consumables v/s Instruments), By Nucleotide Sequenced (DNA v/s RNA), By Type, By Type of Nanopore, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.
The Global Nanopore Sequencing Market stood at USD236.91 million in 2020 and is expected to grow at a robust rate of 15.29% during the forecast period.
This growth can be attributed to the growing demand for long read sequencing technologies for DNA and RNA sequencing worldwide. Additionally, benefits such as affordability, high accuracy, simultaneous detection of sequences and base modifications, among others associated with nanopore sequencing technology are further expected to fuel the market growth through 2026.
Nanopore sequencing provides targeted sequencing with focus on specific genes thereby providing relevant data, optimizing costs and providing path for simplified data analysis. This in turn is expected to support the market growth over the next few years. Besides, the biggest advantage of directly sequencing RNA molecules using the nanopore sequencing is expected to foster the market growth.
In traditional RNA sequencing technologies RNA is first converted to cDNA using amplification or reverse transcription which at time introduces bias in the sequencing. However, with nanopore sequencing direct RNA sequencing can be done and it delivers unbiased, full length and highly specific RNA sequences. All these factors are expected to contribute to the market growth in the next five years.
The Global Nanopore Sequencing Market is segmented by product, nucleotide sequenced, type, type of nanopore, application, end-user, competitional landscape, and regional distribution. Based on product, the market can be split into consumables and instruments. The consumables segment dominated the market in 2020 with a share of around 53.86%.
This can be attributed to surge in use of consumables in wide array of procedures such as DNA sequencing and RNA sequencing. In addition, increase in usage of consumables in formerly unmapped applications such as sequencing of novel viruses is expected to help the segment gain significant share during the forecast period.
The players operating in the market are following strategies such as mergers & acquisitions, new product/technology development and launches in order to stay competitive in the market and having an edge over the competitors.
Major players operating in the Global Nanopore Sequencing Market include
- Oxford Nanopore Technologies Ltd
- Illumnia, Inc.
- F Hoffmann-La Roche AG
- X Genomics, Inc.
- Agilent Technologies Inc.
- NabSys, Inc.
- Sequenom, Inc.
- Quantapore, Inc
- INanoBio Inc
- Thermo Fischer Scientific, Inc.
- Cyclomics BV
- CD Genomics
- Electronic Biosciences, Inc.
Years considered for this report:
- Historical Years: 2016 - 2019
- Base Year: 2020
- Estimated Year: 2021
- Forecast Period: 2022 - 2026
Global Nanopore Sequencing Market, By Product:
Global Nanopore Sequencing Market, By Nucleotide Sequenced:
Global Nanopore Sequencing Market, By Type:
- Direct Current Sequencing
- Synthetic DNA and Horizontal Tunnelling Current Sequencing
- Optical Reading Techniques Sequencing
- Exonuclease Sequencing
Global Nanopore Sequencing Market, By Type of Nanopore:
- Solid State
Global Nanopore Sequencing Market, By Application:
- Human Genomics
- Clinical Research
- Plant Research
- Animal Research
Global Nanopore Sequencing Market, By End-User:
- Biotechnology Companies
- Clinical Laboratories
- Academic & Research Institutes
Global Nanopore Sequencing Market, By Region:
- North America
- United States
- United Kingdom
- South Korea
- South America
- Middle East & Africa
- Saudi Arabia
- South Africa
For more information about this report visit https://www.researchandmarkets.com/r/v4wt45
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900